Cogen JD - Search Results

1

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.

Cogen JD, Oron AP, Gibson RL, Hoffman LR, Kronman MP, Ong T, Rosenfeld M. Cogen JD, et al. Pediatrics. 2017 Feb;139(2):e20162642. doi: 10.1542/peds.2016-2642. Pediatrics. 2017. PMID: 28126911 Free PMC article. Clinical Trial.

2

The pediatric microbiome and the lung.

Tracy M, Cogen J, Hoffman LR. Tracy M, et al. Curr Opin Pediatr. 2015 Jun;27(3):348-55. doi: 10.1097/MOP.0000000000000212. Curr Opin Pediatr. 2015. PMID: 25888147 Free PMC article. Review.

3

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group. Cogen J, et al. Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9. Pediatr Pulmonol. 2015. PMID: 26061914 Free PMC article.

4

Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female.

Cogen JD, Swanson J, Ong T. Cogen JD, et al. Case Rep Pediatr. 2016;2016:2074970. doi: 10.1155/2016/2074970. Epub 2016 Nov 8. Case Rep Pediatr. 2016. PMID: 27895950 Free PMC article.

5

Pseudomonas aeruginosa eradication: Finally moving the needle?

Cogen J, Rosenfeld M. Cogen J, et al. J Cyst Fibros. 2017 May;16(3):309-310. doi: 10.1016/j.jcf.2017.04.001. Epub 2017 Apr 14. J Cyst Fibros. 2017. PMID: 28416146 Free article. No abstract available.

6

Effect of extending the time after bronchodilator administration on identifying bronchodilator responsiveness in a pediatric pulmonary clinic.

Cogen JD, DiBlasi RM, Gibson RL, Debley JS. Cogen JD, et al. Pediatr Pulmonol. 2017 Aug;52(8):984-989. doi: 10.1002/ppul.23752. Epub 2017 Jul 3. Pediatr Pulmonol. 2017. PMID: 28672068 Clinical Trial.

7

Treating Cystic Fibrosis Pulmonary Exacerbations: In the Hospital with a Physician or at Home under Your Own Supervision?

Cogen JD, Rosenfeld M. Cogen JD, et al. Ann Am Thorac Soc. 2018 Feb;15(2):169-170. doi: 10.1513/AnnalsATS.201711-891ED. Ann Am Thorac Soc. 2018. PMID: 29388818 No abstract available.

8

Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.

Cogen JD, Onchiri F, Emerson J, Gibson RL, Hoffman LR, Nichols DP, Rosenfeld M. Cogen JD, et al. Ann Am Thorac Soc. 2018 Jun;15(6):702-709. doi: 10.1513/AnnalsATS.201801-012OC. Ann Am Thorac Soc. 2018. PMID: 29474110 Free PMC article.

9

Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency?

Szczesniak RD, Cogen JD, Rosenfeld M. Szczesniak RD, et al. Among authors: cogen jd. J Cyst Fibros. 2019 Mar;18(2):159-160. doi: 10.1016/j.jcf.2019.02.008. Epub 2019 Feb 26. J Cyst Fibros. 2019. PMID: 30824378 Free PMC article. No abstract available.

10

Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.

Somayaji R, Russell R, Cogen JD, Goss CH, Nick SE, Saavedra MT, Taylor-Cousar JL, Nick JA, Nichols DP. Somayaji R, et al. Among authors: cogen jd. Ann Am Thorac Soc. 2019 Jul;16(7):853-860. doi: 10.1513/AnnalsATS.201811-773OC. Ann Am Thorac Soc. 2019. PMID: 30840835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters